DrugPatentWatch Database Preview
Loxo Oncology Inc Company Profile
What is the competitive landscape for LOXO ONCOLOGY INC, and what generic and branded alternatives to LOXO ONCOLOGY INC drugs are available?
LOXO ONCOLOGY INC has two approved drugs.
Summary for Loxo Oncology Inc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Loxo Oncology Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loxo Oncology Inc | VITRAKVI | larotrectinib | SOLUTION;ORAL | 211710-001 | Nov 26, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Loxo Oncology Inc | VITRAKVI | larotrectinib | CAPSULE;ORAL | 210861-002 | Nov 26, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Loxo Oncology Inc | VITRAKVI | larotrectinib | CAPSULE;ORAL | 210861-001 | Nov 26, 2018 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
